Demand for ‘Affordable’ Recombinant Vaccines in Developing Nations Largely Unmet—FMI Survey
Jan 16, 2019
Global Recombinant Vaccines Sales to Cross US$ 6 Bn in 2019
Valley Cottage, United States - January 16, 2019 /MarketersMedia/ —
The year on year revenue growth of recombinant vaccines landscape is projected to reach its peak post 2020, indicates Future Market Insights.
Relatively safer and affordable, recombinant vaccines are gaining ground worldwide. With growing focus on preventive healthcare, vaccines are gathering momentum at a global level, including developing economies that still continue to struggle with severe demand-supply gap leading to a considerable shortfall in the availability of vaccines. However, a number of leading non-profit organizations are constantly initiating funding collaborations for improved accessibility of critical vaccines across developing countries.
A new Future Market Insights study on the global recombinant vaccines landscape highlights the optimistic revenue growth potential in developing regional markets such as Asia Pacific and Japan. The FMI report also offers an extensive analysis of the current competition scenario – emphasizing exclusive insights drawn by exhaustive primary and secondary market research.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7757
Key Dynamics Analysis Evaluates the Role of Collaborative Activities and R&D
On the backdrop of how Sanofi's acquisition of protein Sciences in 2017 has been boosting the former's Flubok (recombinant vaccines for flu) manufacturing capacity, several players in recombinant vaccines space are strategizing mutual alliances in coming years. Strategic collaborations between leading players in the recombinant vaccines space is likely to provide a strong impetus to the overall market growth.
Moreover, according to WHO, growing prevalence of rare disease instances such as Ebola, Crimean Congo, MERS, hemorrhagic fever, Marburg, Lassa Fever, Nipah, SARS coronavirus diseases, and Rift Valley Fever is attracting R&D interests of recombinant vaccines manufacturers, thereby pushing growth of the market in the near future
FMI Study Positions Western Europe as Growth Engine of Recombinant Vaccines Landscape
Western Europe currently represents just-under 1/3rd share of the global market revenue, attributed to growing government support for vaccine development and vaccination campaigns. Strong presence of key market players in this region and their increasing investments in R&D of recombinant vaccines further accentuate Western Europe’s top performing spot.
The report projects impressive growth prospects for Asia Pacific and Japan in coming years. However, APAC is especially portrayed lucrative owing to dramatically growing healthcare spending and an expanding target population that struggles with highly unmet clinical needs, despite growing consumer awareness about vaccination merits.
Mature regional markets in North America and Europe remain differentiated due to effective presence of leading biopharmaceutical companies that boast of GMP certified sterile manufacturing facilities, contributing significant towards the revenue growth of recombinant vaccines market in these regions.
Segmental Analysis Reveals Neck-on-Neck Competition between Subunit and Attenuated Vaccine Types
Based on the recombinant vaccines market assessment by type, subunit recombinant vaccines currently hold the largest value share but are likely to lose a bit of it to attenuated recombinant vaccines. Both the segments collectively cover around 90% share of the total market revenue.
Applications of recombinant vaccines in human vaccination continue to reflect maximum attractiveness over veterinary applications. A majority of the total market revenue is contributed by recombinant vaccines for humans, as indicated by the report.
Private clinics and dispensaries remain the most preferred channel for vaccines distribution, followed by pharmacies. Hospital pharmacies hold a larger share than retail pharmacies, though latter is poised for promising expansion in coming years.
Request to Browse Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-7757
Top Two Players Represent a Whopping 80% Market Value Share, Concludes Competition Analysis
According to the FMI study, GlaxoSmithKline plc and Merck & Co., Inc. collectively account for more than 80% revenue share in recombinant vaccines marketplace, keeping the landscape highly consolidated. While the former primarily focuses on strategic collaborations, the latter strategizes new product launches for an expanded market share.
GSK's candidate vaccine launched in 2017 claims to prevent pulmonary TB in HIV negative adult patients.
Merck announced the three studies of the first phase of its investigational pneumococcal vaccine, early in 2018.
Competition tracking uncovers a few more important insights that can potentially direct strategy building efforts of competitors in the recombinant vaccines market at a global level.
New market entry aspirants are prominently opting for the adoption of mammalian protein expression systems in recombinant vaccines manufacturing that accelerate the entire production process.
Established players in recombinant vaccines landscape are prioritizing the development of new variants of existing vaccines.
Contractual alliances with non-profit organizations are likely to earn higher profit shares for manufacturing leaders in recombinant vaccines market.
More from Healthcare, Pharmaceuticals and Medical devices Market:
Extremity Tissue Expanders Revenue Projections 2019
MRI Guided Neurosurgical Ablation Global Market Revenue Share 2019
Wearable Sleep Trackers Sales Forecast 2019
Contact Info:
Name: Abhishek Budholiya
Organization: Future Market Insights
Address: 616 Corporate Way,, Suite 2-9018,, Valley Cottage,
Phone: 3479183531
Website: https://www.futuremarketinsights.com/reports/recombinant-vaccines-market
Source: MarketersMedia
Release ID: 471739
More News
‘Tokyo Vice’ Producer & Netflix APAC Production Affairs Chief Suggest Tweaks To Japan’s Support System: “Incentives Can Be Lower So Long As They’re Certain”
Tokyo Vice producer Alex Boden and Netflix’s APAC Content & Studio Production Affairs chief Debra Richards offered some thoughts on how Japan’s new IP360 incentives scheme could be improved to offer better support to international productions during an MPA seminar at the ongoing Tokyo International Film Festival. Introduced last year to replace the existing JLOX […]
BAFTA Names New Chair
BAFTA has a new chair. UKTV commissioning boss Hilary Rosen will succeed Sara Putt at the UK awards body after Putt’s three-year term runs down. Rosen has been Deputy Chair for the past year and will be succeeded in that role by Ade Rawcliffe and Andrew Miller. Rosen is a well-regarded TV commissioner who has […]
Bradley Whitford, Tom Blyth and Krysta Rodriguez on Sorkin’s ‘A Few Good Men’
Bradley Whitford, Tom Blyth and Krysta Rodriguez are starring in a revival of Aaron Sorkin’s breakthrough, “A Few Good Men,” at Lincoln Center Theater.
Lewd, Leering and Reveling in Opera’s Queerness
Heartbeat’s Drag Opera Extravaganza, a yearly event around Halloween, is an off-color pastiche of opera and pop culture. This year: “Queeney Todd.”
Brady Farrar Goes From ‘Dance Moms’ to Choreographing for ABT
At 21, Brady Farrar, a child star for a season of reality television, is the youngest person to have choreographed a dance for the American Ballet Theater.
Hong Kong’s ‘Apartment Horror’ Films Skewer Its Ghastly Property Market
In one of the world’s least affordable housing markets, high-density housing is a backdrop for exploring superstition and socioeconomic anxiety.
A Showcase of Works by the Designer Gio Ponti in New York
From skyscrapers to chairs to whimsical coat hooks, the Milan native Gio Ponti, who died in 1979, left an extraordinary legacy.
Stephen & Simon Cornwell Take On Chairmen Roles At ‘Night Manager’ Producer The Ink Factory As Michele Wolkoff Upped To President
EXCLUSIVE: Stephen and Simon Cornwell have taken on chairmen roles at their Night Manager indie The Ink Factory amid a wave of hires and promotions. The Cornwells, whose father was iconic British spy author John le Carré, have promoted Creative Director Michelle Wolkoff to President and Chief Creative Officer, while Ian Spence becomes Chief Financial […]
‘Tokyo Vice’ Producer, Netflix Executive Urge Changes to Japan’s Production Incentive at MPA Seminar as Government Readies Unified Content Body
“Tokyo Vice” producer Alex Boden and Netflix production policy director Deb Richards urged changes to Japan’s international production incentive at the Motion Picture Association’s annual seminar at the Tokyo International Film Festival, as the government prepares a new body to bring its scattered content-industry support under one roof. Boden, the London-based producer who spent almost […]
Sir Tom Jones 'truly sorry' as he cancels two shows due to illness
Sir Tom has pushed back two concerts in the US on doctor's advice, due to "a bad case of the flu".
Netflix Docuseries ‘The One About Matthew Perry’ Is a Tragic, Mournful Portrait of Addiction: TV Review
There are not a lot of famous people in “The One About Matthew Perry.” None of the late actor’s “Friends” castmates sat for an interview for the three-part Netflix docuseries; neither did Perry’s longtime friend and “Simpsons” star Hank Azaria, who knew Perry as a striving young actor in L.A., or later collaborators like Bradley […]
‘Sex & the City’ Cast Net Worths Revealed, Ranked Ffrom Lowest to Highest
Sex and the City is an iconic TV show that remains in pop culture conversations to this day! The HBO […] The post ‘Sex & the City’ Cast Net Worths Revealed, Ranked Ffrom Lowest to Highest appeared first on Just Jared - Celebrity News, Entertainment News & Photos.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.